Presbyopia

CSF-1 is a preservative-free solution designed as an alternative to reading glasses for patients.

Pipeline treatments for presbyopia, myopia, and demodex are expanding rapidly

Latest innovations within the presbyopic landscape are proving game-changers for better patient treatment.

Physicians share tales of creative workarounds to cope with this condition.

An increase in popularity of the use of handheld electronics is resulting in changes in the postural and behavioral patterns of device users, as well as significant differences between presbyopes and non-presbyopes and between genders.

Researchers report “very good results" in assessing the visual results and patients satisfaction in a series of patients following following implantation of the AcrySof PanOptix trifocal IOL (Alcon).

Veteran optometrist has seen them all and is waiting for the next innovation

See our latest poll results

As the number of presbyopia patients continues to grow, so do their visual demands.

VUITY, developed by Allergan, is the first and only FDA-approved eye drop to treat presbyopia

This poll is for optometrists and eyecare professionals, only. It will close on Friday, November 5, 2021.

Innovative treatment options reflect a shift in focus

See our latest poll results

Orasis Pharmaceuticals drop in development for treating presbyopia

A presbyopia-correcting eyedrop recently received FDA acceptance of its investigational new drug (IND) application

New technology may be able to help ODs’ most challenging patient segment

A presbyopia-correcting eyedrop recently received FDA acceptance of its investigational new drug (IND) application

A presbyopia-correcting eyedrop recently received FDA acceptance of its investigational new drug (IND) application

Two key points to remember when fitting

Potential presbyopia treatment coming

Potential presbyopia treatment coming

quick quiz

These options increase the depth of field to address the symptoms of presbyopia

New drug from Gensight Biologics hits pipeline